IP Library › Granted Patent US 11,835,462
Granted Patent B2
US 11,835,462 · App. 17/172,709 · Granted Dec 5, 2023

Methods and compositions for partitioning a biological sample

Inventor: Felice Alessio Bava (Rome, IT)
Assignee: 10x Genomics, Inc.
G01N21/6458C12Q1/6837C12Q2563/107
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,835,462
App. No.
17/172,709
Filed
Feb 10, 2021
Granted
Dec 5, 2023
Kind
B2
Art Unit
1797
USPC
436/800
Abstract

This disclosure relates to compositions and methods for analyzing a tissue section from a biological sample.

Claims (41)

1. A method of determining abundance and location of a protein in a biological sample, the method comprising:

(a) embedding a plurality of sections of the biological sample into a polymer solution;

(b) generating a plurality of partitions, wherein a partition of the plurality of partitions comprises a section of the plurality of sections of the biological sample;

(c) manipulating each section in order to detect the protein, wherein the manipulating comprises delivering a plurality of analyte capture agents to the biological sample, wherein an analyte capture agent of the plurality of analyte capture agents comprises:

(i) an analyte binding moiety that binds to the protein;

(ii) an analyte binding moiety barcode that uniquely identifies an interaction between the protein and the analyte binding moiety; and

(iii) an analyte capture sequence, wherein the analyte capture sequence hybridizes to a capture domain; and

(d) determining the abundance and location of the protein in the biological sample.

2. The method of claim 1 , wherein the generating the plurality of partitions comprises surrounding the section with a non-aqueous droplet.

3. The method of claim 1 , further comprising determining abundance and location of a second analyte in the biological sample, wherein the second analyte is an mRNA molecule.

4. The method of claim 3 , wherein determining the abundance and location of the second analyte in the biological sample comprises:

(a) contacting the section with a plurality of capture probes, wherein a capture probe of the plurality comprises (i) a second spatial barcode and (ii) a second capture domain that hybridizes to a sequence present in the second analyte;

(b) hybridizing the second analyte to the second capture domain;

(c) extending a 3′ end of the capture probe using the second analyte that is hybridized to the second capture domain as a template to generate an extended capture probe; and

(d) amplifying the extended capture probe.

5. The method of claim 4 , wherein the determining comprises determining (i) the sequence of the spatial barcode or a complement thereof, and (ii) all or a portion of the sequence of the second analyte; and using the determined sequences of (i) and (ii) to identify the location of the second analyte in the biological sample, thereby determining the abundance and the location of the second analyte.

6. The method of claim 1 , wherein the determining step comprises determining the abundance and location of the protein, the method comprising:

(a) contacting the biological sample with a substrate, wherein the substrate comprises a plurality of capture probes, wherein a capture probe of the plurality of capture probes comprises (i) the capture domain and (ii) a spatial barcode;

(b) hybridizing the analyte capture sequence to the capture domain of the capture probe; and

(c) determining (i) all or a part of a sequence corresponding to the analyte binding moiety barcode, and (ii) a sequence corresponding to the spatial barcode, or a complement thereof, and using the determined sequence of (i) and (ii) to identify the abundance and spatial location of the protein in the biological sample.

7. The method of claim 1 , wherein the manipulating further comprises immunofluorescence or immunohistochemistry.

8. The method of claim 1 , further comprising dispensing the section onto a surface and imaging the biological sample.

9. The method of claim 8 , wherein the imaging comprises capillary microscopy, brightfield microscopy, or fluorescent microscopy.

10. The method of claim 1 , wherein the polymer solution comprises a hydrogel.

11. The method of claim 1 , wherein the biological sample is a tissue section sample.

12. The method of claim 1 , wherein the biological sample is from a fresh tissue sample, a frozen tissue sample, or a formalin-fixed, paraffin embedded (FFPE) sample.

13. The method of claim 1 , wherein the plurality of sections are serial sections from the biological sample.

14. The method of claim 13 , wherein the plurality of sections has an average thickness that is about 0.1 to about 100 micrometers.

15. The method of claim 1 , further comprising fixing the biological sample.

16. The method of claim 1 , further comprising permeabilizing the biological sample.

17. A kit comprising:

(a) a polymer solution comprising a hydrogel;

(b) a container for the polymer solution;

(c) one or more non-aqueous droplets to partition a biological sample comprising an analyte;

(d) one or more compositions to manipulate the biological sample, wherein the one or more compositions are selected from the group consisting of:

(i) a plurality of capture probes, wherein a capture probe of the plurality comprises (i) a spatial barcode and (ii) a capture domain that binds to a sequence present in the analyte;

the plurality of analyte capture agents comprising the analyte capture agent

(3); and

(iii) a protein-binding molecule for immunofluorescence or immunohistochemistry; and

(e) instructions for performing the method of claim 1 .

18. The kit of claim 17 , wherein the analyte is an mRNA molecule or a protein.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2021
From: BAVA, FELICE ALESSIO
To: 10X GENOMICS, INC.
Reel/Frame 058332/0045 →
Continuity (2)
Provisional Application 62975168 · Feb 11, 2020
Related Publication 20210247316A1 · Aug 12, 2021
Cited By (45)
US 12,195,790 US 12,203,134 US 12,209,280 US 12,223,751 US 12,228,544 US 12,234,505 US 12,241,060 US 12,241,890 US 12,249,085 US 12,265,079 US 12,270,077 US 12,275,988 US 12,281,357 US 12,286,673 US 12,287,264 US 12,297,486 US 12,297,487 US 12,297,488 US 12,344,892 US 12,365,935 US 12,365,942 US 12,371,688 US 12,378,607 US 12,385,083 US 12,391,979 US 12,391,980 US 12,399,123 US 12,405,264 US 12,416,603 US 12,435,363 US 12,442,045 US 12,497,654 US 12,508,590 US 12,545,949 US 12,553,805 US 12,553,898 US 12,566,113 US 12,566,114 US 12,571,029 US 12,624,475 US 12,637,706 US 12,692,492 US 12,735,743 US 12,742,166 US 12,742,199